In summary, this study proposed a potential regulatory mechanism involving UBC9, SUMOylated Mettl3, and Snail in HCC progression, suggesting Mettl3 SUMOylation as a promising diagnostic and therapeutic target for liver cancer treatment. This evidence concerns the gene METTL3 and liver cancer.